Quepos, Costa Rica

Mark Lefever

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ventana Medical Systems, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Lefever. Retrieved from https://idiyas.com/inventor/mark-lefever-ql8qaezs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Lefever: Inventor in Detectable Conjugates

Introduction

Mark Lefever is an inventor associated with Quepos, Costa Rica. His patent work includes technology for detectable moieties and conjugates used to label targets in biological specimens.

Latest Patents

Lefever is associated with 1 patent: “Conjugates Including a Detectable Moiety.” The patent describes detectable moieties and conjugates that may have narrow wavelength characteristics suitable for multiplexing. It also covers methods for labeling one or more targets within a biological specimen using the disclosed moieties or conjugates.

Career Highlights

Lefever is associated with Ventana Medical Systems, Inc. His listed patent reflects work involving detectable labeling technologies for biological specimens.

Collaborations

The available information connects Lefever’s patent and professional affiliation with Ventana Medical Systems, Inc. Further details about specific collaborators are not provided.

Conclusion

Mark Lefever’s recorded invention focuses on detectable conjugates and labeling methods, representing his contribution to patent activity associated with Ventana Medical Systems, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…